APO RESEARCH · REPORT
Collagen Peptides
Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells.
Product & engineering
Understand the product.
Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells.
Colloquially, collagen is only a part of collagen. Because the molecular weight of collagen ranges from 500 to 30000, the human body can directly absorb it. If it is too small, it is oligopeptide or polypeptide, which is no big difference from amino acid for human body. The larger molecular weight is hundreds of thousands to millions of macromolecules, which is collagen. Human body can't absorb collagen, which is the root of understanding that "collagen" can't be absorbed.
Selected research
Market Outlook & Growth Opportunities
Global Collagen Peptides Market Outlook and Growth Opportunities 2026
Market perspective
Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells.
Colloquially, collagen is only a part of collagen. Because the molecular weight of collagen ranges from 500 to 30000, the human body can directly absorb it. If it is too small, it is oligopeptide or polypeptide, which is no big difference from amino acid for human body. The larger molecular weight is hundreds of thousands to millions of macromolecules, which is collagen. Human body can't absorb collagen, which is the root of understanding that "collagen" can't be absorbed.
Global Collagen Peptides key players include Rousselot S.A.S., Gelita, PB Leiner, etc. Global top three manufacturers hold a share about 35%.
Read the full market overview
Europe is the largest market, with a share about 30%, followed by China, and North America, both have a share about 45 percent.
In terms of product, Porcine collagen is the largest segment, with a share about 35%. And in terms of application, the largest application is Food Industrial, followed by Health Products Industrial, Cosmetics Industrial, etc.
This report provides an overview of the global Collagen Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Collagen Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Collagen Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Collagen Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.
Collagen Peptides Segment by Company
Rousselot S.A.S.
Gelita
PB Leiner
Nitta Gelatin Inc.
NIPPI
BHN
Weishardt International
Neocell
DCP
Lapi Gelatine
Italgelatine
Jiangxi Cosen Biology Co., Ltd
Tai AI peptide group
Beijing Huada Jierui Biotechnology Co., Ltd
Hainan Huayan Collagen Technology Co., Ltd.
Hynixon group
Mingrang biology
SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT.
Baotou Dongbao Bio-Tech Co.Ltd
Shanghai haijiantang group
Beijing SEMNL Biotechnology Co.ltd.
Guangdong Zhongnan Island Biotechnology Co., Ltd
Collagen Peptides Segment by Type
Fish collagen
Bovine collagen
Porcine collagen
Collagen Peptides Segment by Application
Food Industrial
Health Products Industrial
Cosmetics Industrial
Others
Collagen Peptides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Collagen Peptides status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Collagen Peptides market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Collagen Peptides significant trends, drivers, influence factors in global and regions.
6. To analyze Collagen Peptides competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Collagen Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Collagen Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Collagen Peptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Collagen Peptides market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Collagen Peptides industry.
Chapter 3: Detailed analysis of Collagen Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Collagen Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Collagen Peptides in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Fish collagen
- Bovine collagen
- Porcine collagen
Applications
- Food Industrial
- Health Products Industrial
- Cosmetics Industrial
- Others
Companies covered
- Rousselot S.A.S.
- Gelita
- PB Leiner
- Nitta Gelatin Inc.
- NIPPI
- BHN
- Weishardt International
- Neocell
- DCP
- Lapi Gelatine
- Italgelatine
- Jiangxi Cosen Biology Co., Ltd
- Tai AI peptide group
- Beijing Huada Jierui Biotechnology Co., Ltd
- Hainan Huayan Collagen Technology Co., Ltd.
- Hynixon group
- Mingrang biology
- SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT.
- Baotou Dongbao Bio-Tech Co.Ltd
- Shanghai haijiantang group
- Beijing SEMNL Biotechnology Co.ltd.
- Guangdong Zhongnan Island Biotechnology Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Collagen Peptides Sales Value (2021-2032)
- 1.2.2 Global Collagen Peptides Sales Volume (2021-2032)
- 1.2.3 Global Collagen Peptides Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Collagen Peptides Market Dynamics
- 2.1 Collagen Peptides Industry Trends
- 2.2 Collagen Peptides Industry Drivers
- 2.3 Collagen Peptides Industry Opportunities and Challenges
- 2.4 Collagen Peptides Industry Restraints
3 Collagen Peptides Market by Company
- 3.1 Global Collagen Peptides Company Revenue Ranking in 2025
- 3.2 Global Collagen Peptides Revenue by Company (2021-2026)
- 3.3 Global Collagen Peptides Sales Volume by Company (2021-2026)
- 3.4 Global Collagen Peptides Average Price by Company (2021-2026)
- 3.5 Global Collagen Peptides Company Ranking (2024-2026)
- 3.6 Global Collagen Peptides Company Manufacturing Base and Headquarters
- 3.7 Global Collagen Peptides Company Product Type and Application
- 3.8 Global Collagen Peptides Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Collagen Peptides Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Collagen Peptides Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Collagen Peptides Market by Type
- 4.1 Collagen Peptides Type Introduction
- 4.1.1 Fish collagen
- 4.1.2 Bovine collagen
- 4.1.3 Porcine collagen
- 4.2 Global Collagen Peptides Sales Volume by Type
- 4.2.1 Global Collagen Peptides Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Collagen Peptides Sales Volume by Type (2021-2032)
- 4.2.3 Global Collagen Peptides Sales Volume Share by Type (2021-2032)
- 4.3 Global Collagen Peptides Sales Value by Type
- 4.3.1 Global Collagen Peptides Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Collagen Peptides Sales Value by Type (2021-2032)
- 4.3.3 Global Collagen Peptides Sales Value Share by Type (2021-2032)
5 Collagen Peptides Market by Application
- 5.1 Collagen Peptides Application Introduction
- 5.1.1 Food Industrial
- 5.1.2 Health Products Industrial
- 5.1.3 Cosmetics Industrial
- 5.1.4 Others
- 5.2 Global Collagen Peptides Sales Volume by Application
- 5.2.1 Global Collagen Peptides Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Collagen Peptides Sales Volume by Application (2021-2032)
- 5.2.3 Global Collagen Peptides Sales Volume Share by Application (2021-2032)
- 5.3 Global Collagen Peptides Sales Value by Application
- 5.3.1 Global Collagen Peptides Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Collagen Peptides Sales Value by Application (2021-2032)
- 5.3.3 Global Collagen Peptides Sales Value Share by Application (2021-2032)
6 Collagen Peptides Regional Sales and Value Analysis
- 6.1 Global Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Collagen Peptides Sales by Region (2021-2032)
- 6.2.1 Global Collagen Peptides Sales by Region: 2021-2026
- 6.2.2 Global Collagen Peptides Sales by Region (2027-2032)
- 6.3 Global Collagen Peptides Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Collagen Peptides Sales Value by Region (2021-2032)
- 6.4.1 Global Collagen Peptides Sales Value by Region: 2021-2026
- 6.4.2 Global Collagen Peptides Sales Value by Region (2027-2032)
- 6.5 Global Collagen Peptides Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Collagen Peptides Sales Value (2021-2032)
- 6.6.2 North America Collagen Peptides Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Collagen Peptides Sales Value (2021-2032)
- 6.7.2 Europe Collagen Peptides Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Collagen Peptides Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Collagen Peptides Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Collagen Peptides Sales Value (2021-2032)
- 6.9.2 South America Collagen Peptides Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Collagen Peptides Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Collagen Peptides Sales Value Share by Country, 2025 VS 2032
7 Collagen Peptides Country-level Sales and Value Analysis
- 7.1 Global Collagen Peptides Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Collagen Peptides Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Collagen Peptides Sales by Country (2021-2032)
- 7.3.1 Global Collagen Peptides Sales by Country (2021-2026)
- 7.3.2 Global Collagen Peptides Sales by Country (2027-2032)
- 7.4 Global Collagen Peptides Sales Value by Country (2021-2032)
- 7.4.1 Global Collagen Peptides Sales Value by Country (2021-2026)
- 7.4.2 Global Collagen Peptides Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.9.2 France Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.16.2 China Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.19.2 India Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Collagen Peptides Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Collagen Peptides Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Collagen Peptides Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Collagen Peptides Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Rousselot S.A.S.
- 8.1.1 Rousselot S.A.S. Company Information
- 8.1.2 Rousselot S.A.S. Business Overview
- 8.1.3 Rousselot S.A.S. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Rousselot S.A.S. Collagen Peptides Product Portfolio
- 8.1.5 Rousselot S.A.S. Recent Developments
- 8.2 Gelita
- 8.2.1 Gelita Company Information
- 8.2.2 Gelita Business Overview
- 8.2.3 Gelita Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Gelita Collagen Peptides Product Portfolio
- 8.2.5 Gelita Recent Developments
- 8.3 PB Leiner
- 8.3.1 PB Leiner Company Information
- 8.3.2 PB Leiner Business Overview
- 8.3.3 PB Leiner Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.3.4 PB Leiner Collagen Peptides Product Portfolio
- 8.3.5 PB Leiner Recent Developments
- 8.4 Nitta Gelatin Inc.
- 8.4.1 Nitta Gelatin Inc. Company Information
- 8.4.2 Nitta Gelatin Inc. Business Overview
- 8.4.3 Nitta Gelatin Inc. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Nitta Gelatin Inc. Collagen Peptides Product Portfolio
- 8.4.5 Nitta Gelatin Inc. Recent Developments
- 8.5 NIPPI
- 8.5.1 NIPPI Company Information
- 8.5.2 NIPPI Business Overview
- 8.5.3 NIPPI Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.5.4 NIPPI Collagen Peptides Product Portfolio
- 8.5.5 NIPPI Recent Developments
- 8.6 BHN
- 8.6.1 BHN Company Information
- 8.6.2 BHN Business Overview
- 8.6.3 BHN Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.6.4 BHN Collagen Peptides Product Portfolio
- 8.6.5 BHN Recent Developments
- 8.7 Weishardt International
- 8.7.1 Weishardt International Company Information
- 8.7.2 Weishardt International Business Overview
- 8.7.3 Weishardt International Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Weishardt International Collagen Peptides Product Portfolio
- 8.7.5 Weishardt International Recent Developments
- 8.8 Neocell
- 8.8.1 Neocell Company Information
- 8.8.2 Neocell Business Overview
- 8.8.3 Neocell Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Neocell Collagen Peptides Product Portfolio
- 8.8.5 Neocell Recent Developments
- 8.9 DCP
- 8.9.1 DCP Company Information
- 8.9.2 DCP Business Overview
- 8.9.3 DCP Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.9.4 DCP Collagen Peptides Product Portfolio
- 8.9.5 DCP Recent Developments
- 8.10 Lapi Gelatine
- 8.10.1 Lapi Gelatine Company Information
- 8.10.2 Lapi Gelatine Business Overview
- 8.10.3 Lapi Gelatine Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Lapi Gelatine Collagen Peptides Product Portfolio
- 8.10.5 Lapi Gelatine Recent Developments
- 8.11 Italgelatine
- 8.11.1 Italgelatine Company Information
- 8.11.2 Italgelatine Business Overview
- 8.11.3 Italgelatine Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Italgelatine Collagen Peptides Product Portfolio
- 8.11.5 Italgelatine Recent Developments
- 8.12 Jiangxi Cosen Biology Co., Ltd
- 8.12.1 Jiangxi Cosen Biology Co., Ltd Company Information
- 8.12.2 Jiangxi Cosen Biology Co., Ltd Business Overview
- 8.12.3 Jiangxi Cosen Biology Co., Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Jiangxi Cosen Biology Co., Ltd Collagen Peptides Product Portfolio
- 8.12.5 Jiangxi Cosen Biology Co., Ltd Recent Developments
- 8.13 Tai AI peptide group
- 8.13.1 Tai AI peptide group Company Information
- 8.13.2 Tai AI peptide group Business Overview
- 8.13.3 Tai AI peptide group Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Tai AI peptide group Collagen Peptides Product Portfolio
- 8.13.5 Tai AI peptide group Recent Developments
- 8.14 Beijing Huada Jierui Biotechnology Co., Ltd
- 8.14.1 Beijing Huada Jierui Biotechnology Co., Ltd Company Information
- 8.14.2 Beijing Huada Jierui Biotechnology Co., Ltd Business Overview
- 8.14.3 Beijing Huada Jierui Biotechnology Co., Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Beijing Huada Jierui Biotechnology Co., Ltd Collagen Peptides Product Portfolio
- 8.14.5 Beijing Huada Jierui Biotechnology Co., Ltd Recent Developments
- 8.15 Hainan Huayan Collagen Technology Co., Ltd.
- 8.15.1 Hainan Huayan Collagen Technology Co., Ltd. Company Information
- 8.15.2 Hainan Huayan Collagen Technology Co., Ltd. Business Overview
- 8.15.3 Hainan Huayan Collagen Technology Co., Ltd. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Hainan Huayan Collagen Technology Co., Ltd. Collagen Peptides Product Portfolio
- 8.15.5 Hainan Huayan Collagen Technology Co., Ltd. Recent Developments
- 8.16 Hynixon group
- 8.16.1 Hynixon group Company Information
- 8.16.2 Hynixon group Business Overview
- 8.16.3 Hynixon group Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Hynixon group Collagen Peptides Product Portfolio
- 8.16.5 Hynixon group Recent Developments
- 8.17 Mingrang biology
- 8.17.1 Mingrang biology Company Information
- 8.17.2 Mingrang biology Business Overview
- 8.17.3 Mingrang biology Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Mingrang biology Collagen Peptides Product Portfolio
- 8.17.5 Mingrang biology Recent Developments
- 8.18 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT.
- 8.18.1 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Company Information
- 8.18.2 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Business Overview
- 8.18.3 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.18.4 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Collagen Peptides Product Portfolio
- 8.18.5 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Recent Developments
- 8.19 Baotou Dongbao Bio-Tech Co.Ltd
- 8.19.1 Baotou Dongbao Bio-Tech Co.Ltd Company Information
- 8.19.2 Baotou Dongbao Bio-Tech Co.Ltd Business Overview
- 8.19.3 Baotou Dongbao Bio-Tech Co.Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Baotou Dongbao Bio-Tech Co.Ltd Collagen Peptides Product Portfolio
- 8.19.5 Baotou Dongbao Bio-Tech Co.Ltd Recent Developments
- 8.20 Shanghai haijiantang group
- 8.20.1 Shanghai haijiantang group Company Information
- 8.20.2 Shanghai haijiantang group Business Overview
- 8.20.3 Shanghai haijiantang group Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Shanghai haijiantang group Collagen Peptides Product Portfolio
- 8.20.5 Shanghai haijiantang group Recent Developments
- 8.21 Beijing SEMNL Biotechnology Co.ltd.
- 8.21.1 Beijing SEMNL Biotechnology Co.ltd. Company Information
- 8.21.2 Beijing SEMNL Biotechnology Co.ltd. Business Overview
- 8.21.3 Beijing SEMNL Biotechnology Co.ltd. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Beijing SEMNL Biotechnology Co.ltd. Collagen Peptides Product Portfolio
- 8.21.5 Beijing SEMNL Biotechnology Co.ltd. Recent Developments
- 8.22 Guangdong Zhongnan Island Biotechnology Co., Ltd
- 8.22.1 Guangdong Zhongnan Island Biotechnology Co., Ltd Company Information
- 8.22.2 Guangdong Zhongnan Island Biotechnology Co., Ltd Business Overview
- 8.22.3 Guangdong Zhongnan Island Biotechnology Co., Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Guangdong Zhongnan Island Biotechnology Co., Ltd Collagen Peptides Product Portfolio
- 8.22.5 Guangdong Zhongnan Island Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Collagen Peptides Value Chain Analysis
- 9.1.1 Collagen Peptides Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Collagen Peptides Sales Mode & Process
- 9.2 Collagen Peptides Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Collagen Peptides Distributors
- 9.2.3 Collagen Peptides Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst